Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimer's Disease

The Cognition Maintenance Study is a 6-month, Randomized Controlled Trial of Simufilam in Over 125 Patients with Alzheimer’s Disease.Primary Outcome Measures Are Safety and Change in Cognition... | May 11, 2023

Related Keywords

Texas ,United States ,Eric Schoen ,Remi Barbier ,Cassava Sciences Inc ,Nasdaq ,Cassava Sciences ,Cognition Maintenance Study ,Randomized Controlled Trial ,Outcome Measures Are Safety ,Clinical Results ,Cassava Science ,More Information Contact ,Chief Financial ,Note Regarding Forward Looking Statements ,Private Securities Litigation Reform Act ,Nc Stock Exchange ,News ,Information ,Press Release ,The ,Cognition ,Maintenance ,Study ,Us ,Randomized ,Ontrolled ,Trial ,F ,Simufilam ,N ,Dover ,25 ,Patients ,Ith ,Outcome ,Measures ,Fire ,Safety ,End ,Change ,N Sava Us14817c1071 ,